[PDF][PDF] Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.

M Lagadinou, N Zareifopoulos… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: Complete blood count parameters are frequently altered in COVID-19 patients.
Leucopenia and lymphopenia are the most common findings. This is not specific to COVID …

Analysis of TCR repertoire by high-throughput sequencing indicates the feature of T cell immune response after SARS-CoV-2 infection

Y Wang, F Duan, Z Zhu, M Yu, X Jia, H Dai, P Wang… - Cells, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a global infectious disease caused by the SARS-
CoV-2 coronavirus. T cells play an essential role in the body's fighting against the virus …

[HTML][HTML] Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals

N Jo, R Zhang, H Ueno, T Yamamoto, D Weiskopf… - Frontiers in …, 2021 - frontiersin.org
Age is a major risk factor for COVID-19 severity, and T cells play a central role in anti-SARS-
CoV-2 immunity. Because SARS-CoV-2-cross-reactive T cells have been detected in …

[PDF][PDF] Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection

Q Zeng, X Qi, J Ma, F Hu, X Wang, H Qin, M Li… - Iscience, 2022 - cell.com
MicroRNAs (miRNAs) have been shown to play important roles in viral infections, but their
associations with SARS-CoV-2 infection remain poorly understood. Here, we detected 85 …

T cell responses to SARS-CoV-2 in humans and animals

SS Mattoo, J Myoung - Journal of Microbiology, 2022 - Springer
Abstract SARS-CoV-2, the causative agent of COVID-19, first emerged in 2019. Antibody
responses against SARS-CoV-2 have been given a lot of attention. However, the …

Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia

AR Schuurman, TDY Reijnders, A Saris… - Elife, 2021 - elifesciences.org
The exact immunopathophysiology of community-acquired pneumonia (CAP) caused by
SARS-CoV-2 (COVID-19) remains clouded by a general lack of relevant disease controls …

[HTML][HTML] Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

J Bordat, S Maury, M Leclerc - Frontiers in Immunology, 2023 - frontiersin.org
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …

[HTML][HTML] Immune profiling of COVID-19: preliminary findings and implications for the pandemic

HT Maecker - Journal for immunotherapy of cancer, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 infection can have widely diverse clinical outcomes, from asymptomatic
infection to death, with many possible clinical symptoms and syndromes. It is thus essential …

An update on protective effectiveness of immune responses after recovery from COVID-19

S Soleimanian, S Alyasin, N Sepahi… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits variable immunity
responses among hosts based on symptom severity. Whether immunity in recovered …

[HTML][HTML] A promising vaccination strategy against COVID-19 on the horizon: heterologous immunization

J Myoung - Journal of microbiology and biotechnology, 2021 - ncbi.nlm.nih.gov
To overcome the ongoing COVID-19 pandemic, vaccination campaigns are the highest
priority of majority of countries. Limited supply and worldwide disproportionate availability …